Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: A case report

0Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Background: Immunosuppressive therapy has been - until the recent release of new guidelines on diagnosis and management - the recommended treatment for idiopathic pulmonary fibrosis. However, its efficacy in patients with idiopathic pulmonary fibrosis has always been a matter of debate. Case presentation: We report the occurrence of idiopathic pulmonary fibrosis in a white man receiving chronic immunosuppressive treatment following a heart transplant. Conclusions: This case report suggests that the immune mechanisms targeted by azathioprine and cyclosporine do not play a role in the pathogenesis of idiopathic pulmonary fibrosis.

References Powered by Scopus

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management

6191Citations
N/AReaders
Get full text

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

3555Citations
N/AReaders
Get full text

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

3074Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cerri, S., Sgalla, G., Richeldi, L., & Luppi, F. (2016). Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: A case report. Journal of Medical Case Reports, 10(1). https://doi.org/10.1186/s13256-016-0916-5

Readers' Seniority

Tooltip

Researcher 3

60%

Professor / Associate Prof. 1

20%

PhD / Post grad / Masters / Doc 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

67%

Pharmacology, Toxicology and Pharmaceut... 1

11%

Nursing and Health Professions 1

11%

Computer Science 1

11%

Save time finding and organizing research with Mendeley

Sign up for free